Sanofi Deepens Investment in mRNA Vaccines with Translate Bio Collaboration
By Heather Cartwright
Pharma Deals Review: Vol 2018 Issue 6 (Table of Contents)
Published: 26 Jun-2018
DOI: 10.3833/pdr.v2018.i6.2329 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
Less than 2 weeks after filing for an IPO, Translate Bio has secured a high-profile R&D partnership with Sanofi Pasteur, the vaccines unit of Sanofi, to develop next-generation mRNA vaccines for up to five undisclosed infectious disease pathogens...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS